MSC therapy for scleroderma is not covered by standard insurance. HSCT may be covered by some national health systems or insurance if performed within approved clinical trials or at recognised transplant centres for severe, rapidly progressive disease, but availability is limited.
Placental MSC infusion for scleroderma costs €5,000–8,500 per treatment course, with many protocols involving two to three infusions spaced weeks to months apart. Autologous HSCT is substantially more expensive (€35,000–60,000), reflecting hospitalisation, high-dose chemotherapy conditioning, stem-cell mobilisation and reinfusion, and intensive post-transplant monitoring. Baseline assessments (skin biopsy, pulmonary function, cardiac imaging) add €2,000–3,500. Long-term immunosuppression post-HSCT incurs ongoing medication costs.
我是候选人吗？ → · Scleroderma (Systemic Sclerosis): full overview → · 硬皮病（系统性硬化症）成本 → · Cost →
由 StemCellAtlas 的编辑团队进行医学审查，与Dr Polina Krasenova (Haematologist · Clinical Haematology & Integrative Oncology · 15+ yrs cell therapy) 合作诊所 Stem Plus（索菲亚）的，根据 ISSCR、FDA 和 EMA 指南。 Educational information, not medical advice; figures indicative.
位于欧盟核心的 GMP 认证再生医学诊所——费用 3,000–8,000 欧元起，仅为美国或德国价格的一小部分。为来自 50 多个国家的国际患者提供个性化方案。
免费医疗评估